國立高雄大學圖資館 |

Language: English

Back

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Unhealthy pharmaceutical regulation :Courtney Davis, Kings College London, UK and John Abraham, University of Sussex, UK.
Reminder of title:	innovation, politics and promissory science /
Author:	Abraham, John,
other author:	Davis, Courtney,
Description:	1 online resource.
Subject:	DrugsLaw and legislationEuropean Union countries.
Online resource:	https://link.springer.com/book/10.1057/9781137349477
ISBN:	1137349476 (electronic bk.)

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /
Abraham, John,1961-

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /Courtney Davis, Kings College London, UK and John Abraham, University of Sussex, UK. - 1 online resource.

Includes bibliographical references and index.

Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health -- The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era -- Designs on Diabetes Drugs -- Desperate Regulation for Desperate Cancer Patients -- The Making of a Harmful 'Therapeutic Breakthrough' -- The Regulatory Science and Politics of Risk Management -- Conclusions and Policy Implications.

"European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health. "--

ISBN: 1137349476 (electronic bk.)

Source: 518163Palgrave Macmillanhttp://www.palgraveconnect.comSubjects--Topical Terms:

461675
Drugs
--Law and legislation--European Union countries.Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RA401.A1 / A27 2013

Dewey Class. No.: 362.17/82

Unhealthy pharmaceutical regulation :innovation, politics and promissory science /
LDR:03166cmm a2200385Ki 4500 001 438256
003 OCoLC
005 20140910115744.0
006 m o d
007 cr cnu---unuuu
008 150123s2013 nyu ob 001 0 eng d
020 $a 1137349476 (electronic bk.)
020 $a 9781137349477 (electronic bk.)
029 1 $a NLGGC $b 371078407
035 $a (OCoLC)863036824
035 $a ocn863036824
037 $a 518163 $b Palgrave Macmillan $n http://www.palgraveconnect.com
040 $a UKPGM $b eng $e rda $e pn $c UKPGM $d OCLCO $d IDEBK $d CDX $d N $d YDXCP $d E7B $d OCLCO
043 $a n-us--- $a e------
049 $a TEFA
050 4 $a RA401.A1 $b A27 2013
072 7 $a POL $x 019000 $2 bisacsh
072 7 $a POL $x 027000 $2 bisacsh
082 0 4 $a 362.17/82 $2 23
100 1 $a Abraham, John, $d 1961- $e author. $3 686154
245 1 0 $a Unhealthy pharmaceutical regulation : $b innovation, politics and promissory science / $c Courtney Davis, Kings College London, UK and John Abraham, University of Sussex, UK.
264 1 $a New York, NY : $b Palgrave Macmillan, $c 2013.
300 $a 1 online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
504 $a Includes bibliographical references and index.
505 0 $a Putting Pharmaceutical Regulation to the Test: A Social Science for Public Health -- The Political Economy of 'Innovative' Drug Regulation in the Neo-Liberal Era -- Designs on Diabetes Drugs -- Desperate Regulation for Desperate Cancer Patients -- The Making of a Harmful 'Therapeutic Breakthrough' -- The Regulatory Science and Politics of Risk Management -- Conclusions and Policy Implications.
520 $a "European and American drug regulators govern a multi-billion-dollar pharmaceutical industry selling its products on the world's two largest medicines markets. This is the first book to investigate how effectively American and supranational EU governments have regulated innovative pharmaceuticals regarding public health during the neo-liberal era of the last 30 years. Drawing on years of fieldwork, the authors demonstrate that pharmaceutical regulation and innovation have been misdirected by commercial interests and misconceived ideologies, which induced a deregulatory political culture contrary to health interests. They dismantle the myth that pharmaceutical innovations necessarily equate with therapeutic advances and explain how it has been perpetuated in the interests of industry by corporate bias within the regulatory state, unwarranted expectations of promissory science, and the emergent patient-industry complex. Endemic across both continents, the misadventures of pharmaceutical deregulation are shown to span many therapeutic areas, including cancer, diabetes and irritable bowel syndrome. The authors propose political changes needed to redirect pharmaceutical regulation in the interests of health. "-- $c Provided by publisher.
588 $a Description based on print version record.
650 0 $a Drugs $x Law and legislation $z European Union countries. $3 461675
650 0 $a Drugs $x Law and legislation $z United States. $3 239987
650 0 $a Pharmaceutical industry $x Political aspects. $3 686156
650 0 $a Pharmaceutical policy $z European Union countries. $3 686157
650 0 $a Pharmaceutical policy $z United States. $3 239986
650 7 $a MEDICAL / Health Policy. $2 bisacsh $3 686158
650 7 $a MEDICAL / Pharmacy. $2 bisacsh $3 686159
650 7 $a POLITICAL SCIENCE / Public Policy / General. $2 bisacsh $3 565361
650 7 $a POLITICAL SCIENCE / Public Policy / Social Security $2 bisacsh $3 565434
650 7 $a POLITICAL SCIENCE / Public Policy / Social Services & Welfare $2 bisacsh $3 565435
650 7 $a SOCIAL SCIENCE / Disease & Health Issues. $2 bisacsh $3 566179
650 7 $a SOCIAL SCIENCE / Sociology / General. $2 bisacsh $3 564578
655 4 $a Electronic books. $2 local. $3 214472
700 1 $a Davis, Courtney, $d 1965- $e author. $3 686155
776 0 8 $i Print version: $a Abraham, John, 1961- author. $t Unhealthy pharmaceutical regulation $z 9780230008663 $w (DLC) 2013021799 $w (OCoLC)144227252
856 4 0 $3 Palgrave Connect $u https://link.springer.com/book/10.1057/9781137349477